{
  "authors": [
    {
      "author": "Renhua Guo"
    },
    {
      "author": "Xiaofen Chen"
    },
    {
      "author": "Tongshan Wang"
    },
    {
      "author": "Zhiyuan Zhang"
    },
    {
      "author": "Jin Sun"
    },
    {
      "author": "Yongqian Shu"
    }
  ],
  "doi": "10.1186/1471-2407-11-90",
  "publication_date": "2011-03-04",
  "id": "EN117426",
  "url": "https://pubmed.ncbi.nlm.nih.gov/21366910",
  "source": "BMC cancer",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "Two patients with advanced or metastatic NSCLC were treated with palliative chemotherapy followed by erlotinib/gefitinib. When TKI therapy failed, two cycles of chemotherapy were provided, which were followed by re-challenge with erlotinib or gefitinib."
}